down arrow

Fischer Medical

  • Market Cap: Mid Cap
  • Industry: Chemicals
  • ISIN: INE771F01025
  • NSEID:
  • BSEID: 524743
INR
834.80
14.8 (1.8%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.62 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

805.00860.00

52 Week

454.35919.00
Valuation
Technical
Day's Volume

CASH

1.62 lacs (2,025.47%) Volume

Shareholding (Feb 2025)

FII

5.06%

Held by 3 FIIs

DII

1.41%

Held by 0 DIIs

Promoter

62.81%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.68
  • The company has been able to generate a Return on Equity (avg) of 2.29% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

 
3

With ROE of 2.3, it has a Very Expensive valuation with a 64.9 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 5,225 Cr (Mid Cap)

stock-summary
P/E

2,843.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

2.28%

stock-summary
Price to Book

64.93

Revenue and Profits (1 Year):
Net Sales:
12 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
24.6%
0%
24.6%
1 Year
28.77%
0%
28.77%
2 Years
893.81%
0%
893.81%
3 Years
1146.9%
0%
1146.9%
4 Years
3173.73%
0%
3173.73%
5 Years
1581.37%
0%
1581.37%

Fischer Medical for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.76%
ROCE (avg)
0.06%
ROE (avg)
2.29%
Valuation key factors
Factor
Value
P/E Ratio
2843
Industry P/E
41
Price to Book Value
64.93
EV to EBIT
3111.74
EV to EBITDA
2810.61
EV to Capital Employed
68.26
EV to Sales
249.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.19%
ROE (Latest)
2.28%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (5.06%)

Promoter with highest holding

Time Medical International Ventures Pte (52.0%)

Highest Public shareholder

Roopal Hitesh Kawa (0%)

Individual Investors Holdings

25.3%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -60.78% vs -39.29% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.22",
          "val2": "-0.36",
          "chgp": "38.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.20",
          "val2": "0.51",
          "chgp": "-60.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -100.00% vs 0.00% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 4,400.00% vs 127.27% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.19",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.47",
          "val2": "0.05",
          "chgp": "-1,040.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.02",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.35",
          "val2": "0.03",
          "chgp": "4,400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "26.32%",
          "chgp": "-26.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -100.00% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1,650.00% vs 33.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.19",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.69",
          "val2": "-0.07",
          "chgp": "-885.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.05",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.55",
          "val2": "-0.10",
          "chgp": "1,650.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-36.84%",
          "chgp": "36.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6,305.56% vs 0.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 1,100.00% vs 82.61% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.53",
          "val2": "0.18",
          "chgp": "6,305.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.19",
          "val2": "0.05",
          "chgp": "-480.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.05",
          "chgp": "-60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.40",
          "val2": "-0.04",
          "chgp": "1,100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.65%",
          "val2": "27.78%",
          "chgp": "-29.43%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.22
-0.36
38.89%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.20
0.51
-60.78%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -60.78% vs -39.29% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.19
-100.00%
Operating Profit (PBDIT) excl Other Income
-0.47
0.05
-1,040.00%
Interest
0.00
0.02
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.35
0.03
4,400.00%
Operating Profit Margin (Excl OI)
0.00%
26.32%
-26.32%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -100.00% vs 0.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 4,400.00% vs 127.27% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.19
-100.00%
Operating Profit (PBDIT) excl Other Income
-0.69
-0.07
-885.71%
Interest
0.00
0.05
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.55
-0.10
1,650.00%
Operating Profit Margin (Excl OI)
0.00%
-36.84%
36.84%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -100.00% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 1,650.00% vs 33.33% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
11.53
0.18
6,305.56%
Operating Profit (PBDIT) excl Other Income
-0.19
0.05
-480.00%
Interest
0.02
0.05
-60.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.40
-0.04
1,100.00%
Operating Profit Margin (Excl OI)
-1.65%
27.78%
-29.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 6,305.56% vs 0.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 1,100.00% vs 82.61% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Fischer Medical Ventures Ltd stock-summary
stock-summary
Fischer Medical Ventures Ltd
Mid Cap
Chemicals
Fischer Chemic Ltd. was incorporated as a Public Limited Company and obtained Certificate of Commencement of Business. The Company formed an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Chennai to take over the partnership business as a going concern dated 19th January 1994. The partnership firm was engaged in the processing/Manufacturing of Laboratory Grade Chemicals.
Company Coordinates stock-summary
Company Details
104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W) Mumbai Maharashtra : 400067
stock-summary
Tel:
stock-summary
http://www.fischerchemic.in
stock-summary
fischerchemicltd@gmail.com
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."